Becton, Dickinson and Company
BD
BDX · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $21.8B
- Assets
- $55.3B
- SEC filing
- DEF 14A
- Filed
- December 18, 2025
Executive Compensation
Compensation reported for BD’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Thomas E. Polen
Chairman, Chief Executive Officer And President
$17.1M
Reported total
- Salary
- $1,395,463
- Stock awards
- $9,991,854
- Incentives
- $1,852,010
- Option awards
- $3,311,861
- Other
- $577,951
Christopher J. Del Orefice
Executive Vice President And Chief Financial Officer
$5.9M
Reported total
- Salary
- $837,500
- Stock awards
- $3,140,481
- Incentives
- $722,500
- Option awards
- $1,040,916
- Other
- $135,767
Michael C. Feld
Executive Vice President, Chief Revenue Officer And President, Life Sciences Segment
$4.1M
Reported total
- Salary
- $775,000
- Stock awards
- $1,641,596
- Incentives
- $533,588
- Option awards
- $544,118
- Other
- $602,054
Michael D. Garrison
Executive Vice President And President, Medical Essentials And Bio Pharma Systems Segments
$3.6M
Reported total
- Salary
- $768,750
- Stock awards
- $1,641,596
- Incentives
- $533,588
- Option awards
- $544,118
- Other
- $160,988
Richard E. Byrd
Executive Vice President And President, Interventional Segment
$3.4M
Reported total
- Salary
- $756,250
- Stock awards
- $1,427,531
- Incentives
- $592,875
- Option awards
- $473,139
- Other
- $149,262
Thomas E. Polen
Chairman, Chief Executive Officer And President
$17.1M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed December 18, 2025.
- Salary
- $1.4M
- Stock Awards
- $10M
- Option Awards
- $3.3M
- Incentives
- $1.9M
- Other
- $578K
Historical Compensation
Thomas E. Polen total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,395,463 | $9,991,854 | $17,129,140 |
| 2024 | $1,354,813 | $9,244,553 | $17,314,606 |
| 2023 | $1,315,625 | $9,491,982 | $17,309,938 |
Named Executive Officers
Thomas E. Polen
Chairman, Chief Executive Officer And President
BD · BDX
$17.1M
FY 2025 · DEF 14A
Christopher J. Del Orefice
Executive Vice President And Chief Financial Officer
BD · BDX
$5.9M
FY 2025 · DEF 14A
Richard E. Byrd
Executive Vice President And President, Interventional Segment
BD · BDX
$3.4M
FY 2025 · DEF 14A
Michael C. Feld
Executive Vice President, Chief Revenue Officer And President, Life Sciences Segment
BD · BDX
$4.1M
FY 2025 · DEF 14A
Michael D. Garrison
Executive Vice President And President, Medical Essentials And Bio Pharma Systems Segments
BD · BDX
$3.6M
FY 2025 · DEF 14A
Source information
- Company
- Becton, Dickinson and Company
- Ticker
- BDX · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- December 18, 2025
- SEC accession number
- 0001628280-25-057846
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →